Drugs / N0750
last change Apr 2026 re-read 2 minutes ago

N0750

Developed for
diabetic polyneuropathy
Investigated by
Eurofarma Laboratorios S.A.

Trials 1 · a red edge is where a trial was stopped

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT06715462 Apr 2026 → Mar 2028 diabetic polyneuropathy Eurofarma Laboratorios S.A. Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as N0750 “Drug: N0750NCT06715462